Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion | Doc History | Novartis Ireland Limited

Home
Medicines
Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion

Name:
Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion
Company:
Novartis Ireland Limited
Active Ingredients:
Tisagenlecleucel Cell Dispersion
Legal Category:
Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 16/04/20

Summary of Product Characteristics last updated on medicines.ie: 28/4/2020

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Company Products

Medicine Name	Active Ingredients
Medicine Name Aclasta 5 mg solution for infusion	Active Ingredients Zoledronic acid monohydrate
Medicine Name Afinitor Tablets	Active Ingredients Everolimus
Medicine Name Aimovig	Active Ingredients Erenumab
Medicine Name Atectura Breezhaler	Active Ingredients Mometasone Furoate, Indacaterol acetate
Medicine Name Atriance 5 mg/ml solution for infusion	Active Ingredients Nelarabine
Medicine Name Azarga 10mg/ml + 5mg/ml eye drops, suspension	Active Ingredients Brinzolamide, Timolol Maleate
Medicine Name Azopt 10mg/ml eye drops suspension	Active Ingredients Brinzolamide
Medicine Name Beovu 120 mg/ml solution for injection in pre-filled syringe	Active Ingredients Brolucizumab
Medicine Name Cataflam 50 mg Coated Tablets	Active Ingredients Diclofenac Potassium
Medicine Name Certican Tablets	Active Ingredients Everolimus
Medicine Name CILOXAN 3 mg/ml ear drops, solution	Active Ingredients Ciprofloxacin hydrochloride
Medicine Name Co-Diovan 160 mg/12.5 mg film-coated tablets	Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 160mg/25mg film-coated tablets	Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 320mg/12.5mg film-coated tablets	Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 320mg/25mg film-coated tablets	Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Co-Diovan 80mg/12.5mg film-coated tablets	Active Ingredients Hydrochlorothiazide, Valsartan
Medicine Name Cosentyx 150 mg solution for injection in pre-filled pen	Active Ingredients secukinumab
Medicine Name Desferal 500mg Vials	Active Ingredients Desferrioxamine Mesylate
Medicine Name Diovan 160 mg film-coated tablets	Active Ingredients Valsartan
Medicine Name Diovan 320mg film-coated tablets	Active Ingredients Valsartan
Medicine Name Diovan 3mg/ml Oral Solution	Active Ingredients Valsartan
Medicine Name Diovan 40 mg film-coated tablets	Active Ingredients Valsartan
Medicine Name Diovan 80 mg film-coated tablets	Active Ingredients Valsartan
Medicine Name DuoTrav Eye Drops Solution	Active Ingredients Timolol Maleate, Travoprost
Medicine Name Enerzair Breezhaler	Active Ingredients Glycopyrronium bromide, Mometasone Furoate, indacaterol acetate

Items Per Page :

1 - 0 of 118 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 28 April 2020 SPC

Reasons for updating

New SPC for medicines.ie

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 16 April 2020 SPC

Reasons for updating

New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)